AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 191 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,228 | -21.5% | 1,441 | -31.1% | 0.00% | – |
| Q1 2024 | $10,476 | -37.4% | 2,091 | 0.0% | 0.00% | -100.0% |
| Q4 2023 | $16,728 | +3.0% | 2,091 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $16,247 | +16.5% | 2,091 | +45.1% | 0.00% | 0.0% |
| Q2 2023 | $13,949 | -11.7% | 1,441 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $15,793 | +263116.7% | 1,441 | 0.0% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 1,441 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $11,000 | -42.1% | 1,441 | -21.7% | 0.00% | 0.0% |
| Q2 2022 | $19,000 | -17.4% | 1,841 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $23,000 | -46.5% | 1,841 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $43,000 | +26.5% | 1,861 | +20.8% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | +70.0% | 1,541 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $20,000 | +17.6% | 1,541 | +18.1% | 0.00% | – |
| Q1 2021 | $17,000 | – | 1,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 188,500 | $4,311,000 | 3.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 334,500 | $7,647,000 | 1.70% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 131,760 | $3,013,000 | 1.49% |
| NEA Management Company, LLC | 3,069,834 | $70,207,000 | 1.42% |
| Berry Street Capital Management LLP | 575,000 | $13,151,000 | 1.36% |
| Melqart Asset Management (UK) Ltd | 916,321 | $20,956,000 | 1.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $2,287,000 | 0.93% |
| HighMark Wealth Management LLC | 50,499 | $1,155,000 | 0.73% |
| Artal Group S.A. | 1,000,000 | $22,870,000 | 0.62% |
| Vigilare Wealth Management | 34,925 | $799,000 | 0.47% |